7M Aveanna (AVAH) shares sold by entities tied to Paul Vigano

Rhea-AI Filing Summary

Aveanna Healthcare Holdings insider update: Investment entities associated with Paul R. Vigano, a ten percent owner, reported open-market sales of an aggregate 7,000,000 shares of Aveanna common stock on June 3, 2026 at $6.24 per share.

The sales were made indirectly through J.H. Whitney VII, L.P., JHW Iliad Holdings LLC and JHW Iliad Holdings II LLC. After these transactions, J.H. Whitney VII, L.P. held 13,450,547 shares, JHW Iliad Holdings LLC held 2,412,602 shares and JHW Iliad Holdings II LLC held 252,899 shares. Additional indirect holdings remained at PSA Iliad Holdings LLC with 1,426,034 shares and PSA Healthcare Investment Holdings LLC with 15,523,810 shares, while Vigano reported no Aveanna shares held directly.

Insights

Insider trading analyst

Large indirect share sale by Vigano-linked funds, with sizable positions retained.

Paul R. Vigano, identified as a ten percent owner, reported aggregate open-market sales of 7,000,000 Aveanna common shares at $6.24. These transactions were executed by affiliated investment entities rather than through direct personal holdings.

The filing also shows substantial remaining indirect positions: J.H. Whitney VII, L.P. at 13,450,547 shares, PSA Healthcare Investment Holdings LLC at 15,523,810 shares, and other entities with multi‑hundred‑thousand share stakes as of June 3, 2026. Footnotes state that Vigano and the controlling entities may be deemed to share voting and dispositive power but disclaim beneficial ownership beyond their pecuniary interest.

No derivative positions are listed, and the transaction pattern is a straightforward net sell without option exercises or tax‑related entries. The economic and signaling impact depends on how these indirect sales relate to Aveanna’s overall share count, which is not detailed in this data alone.

Insider Trade Summary

Net Seller: 7,000,000 shares

Net Sell 6 txns

Insider VIGANO PAUL R

Role 10% Owner

Sold 7,000,000 shs ($43.68M)

Type	Security	Shares	Price	Value
Sale	Common Stock, $0.01 par value	5,842,240	$6.24	$36.46M
Sale	Common Stock, $0.01 par value	1,047,913	$6.24	$6.54M
Sale	Common Stock, $0.01 par value	109,847	$6.24	$685K
holding	Common Stock, $0.01 par value	--	--	--
holding	Common Stock, $0.01 par value	--	--	--
holding	Common Stock, $0.01 par value	--	--	--

Holdings After Transaction: Common Stock, $0.01 par value — 13,450,547 shares (Indirect, By J.H. Whitney VII, L.P.); Common Stock, $0.01 par value — 2,412,602 shares (Indirect, By JHW Iliad Holdings LLC); Common Stock, $0.01 par value — 252,899 shares (Indirect, By JHW Iliad Holdings II LLC); Common Stock, $0.01 par value — 0 shares (Direct); Common Stock, $0.01 par value — 15,523,810 shares (Indirect, By PSA Healthcare Investment Holdings LLC); Common Stock, $0.01 par value — 1,426,034 shares (Indirect, By PSA Iliad Holdings LLC)

Footnotes (4)

1. F1. J.H. Whitney Equity Partners VII, LLC ("Equity Partners VII") is the general partner of J.H. Whitney VII, L.P. ("JHW VII") and Whitney Strategic Partners VII, L.P. ("Strategic Partners VII"). Strategic Partners VII is the managing member of each of PSA Healthcare Investment Holdings LLC ("PSA Healthcare") and PSA Iliad Holdings LLC ("PSA Iliad Holdings"). As a result, Equity Partners VII may be deemed to share voting and dispositive power with respect to shares of common stock, $0.01 par value per share (the "Shares"), held by each of JHW VII, PSA Healthcare and PSA Iliad Holdings, and Strategic Partners VII may be deemed to share voting and dispositive power with respect to the Shares held by each of PSA Healthcare and PSA Iliad Holdings. Each of Equity Partners VII and Strategic Partners VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein.
2. F2. Project Iliad Managing Member, LLC ("Project Iliad") is the managing member of JHW Iliad Holdings LLC ("JHW Iliad"). As a result, Project Iliad may be deemed to share voting and dispositive power with respect to the Shares held by JHW Iliad. Project Iliad disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein.
3. F3. J.H. Whitney Capital Partners, LLC ("Capital Partners") is the sole member of J.H. Whitney VII Management Co., LLC ("Management Co. VII"), which is the managing member of JHW Iliad Holdings II LLC ("JHW Iliad II," and, collectively with PSA Healthcare, JHW Iliad, and PSA Iliad Holdings, the "Stockholder Entities"). As a result, each of Capital Partners and Management Co. VII may be deemed to share voting and dispositive power with respect to the Shares held by JHW Iliad II. Each of Capital Partners and Management Co. VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein.
4. F4. Paul R. Vigano is a Managing Member of Equity Partners VII, a Member of Project Iliad and a Senior Managing Director of Capital Partners. As a result, the undersigned may be deemed to share voting and dispositive power with respect to the Shares held by the Stockholder Entities. The undersigned disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

Key Figures

Shares sold: 7,000,000 shares Sale price: $6.24 per share J.H. Whitney VII holdings: 13,450,547 shares +5 more

8 metrics

Shares sold 7,000,000 shares Aggregate open-market sales on June 3, 2026

Sale price $6.24 per share Price for Aveanna common stock sales on June 3, 2026

J.H. Whitney VII holdings 13,450,547 shares Indirect Aveanna common stock holdings after transactions

JHW Iliad Holdings LLC holdings 2,412,602 shares Indirect Aveanna holdings as of June 3, 2026

JHW Iliad Holdings II LLC holdings 252,899 shares Indirect Aveanna holdings after reported sales

PSA Healthcare Investment Holdings holdings 15,523,810 shares Indirect Aveanna holdings as of June 3, 2026

PSA Iliad Holdings holdings 1,426,034 shares Indirect Aveanna holdings as of June 3, 2026

Direct holdings by Vigano 0 shares Direct Aveanna common stock position after transactions

Key Terms

open-market sale, beneficial ownership, voting and dispositive power, pecuniary interest, +1 more

5 terms

open-market sale financial

"transaction_action": "open-market sale""

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

beneficial ownership financial

"disclaims beneficial ownership of such securities except to the extent"

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

voting and dispositive power financial

"may be deemed to share voting and dispositive power with respect to the Shares"

pecuniary interest financial

"disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein"

ten percent owner financial

"reportingPersons": [{"name": "VIGANO PAUL R" ... "is_ten_percent_owner": 1"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 06/05/2026 - 11:32 AM Accepted by SEC EDGAR 06/05/2026 - 11:32 AM Learn about SEC filing dates

FAQ

What did Paul R. Vigano-related entities report in this Aveanna (AVAH) Form 4?

Entities associated with Paul R. Vigano reported open-market sales of 7,000,000 Aveanna common shares at $6.24 per share on June 3, 2026. The transactions were indirect, executed through several J.H. Whitney-affiliated and PSA-branded investment vehicles that still retain significant shareholdings.

How many Aveanna (AVAH) shares were sold and at what price in this filing?

The filing shows total open-market sales of 7,000,000 Aveanna common shares at $6.24 per share on June 3, 2026. These sales were spread across multiple indirect holding entities linked to Paul R. Vigano, rather than from directly held personal shares.

Which entities linked to Paul R. Vigano sold Aveanna (AVAH) shares?

J.H. Whitney VII, L.P., JHW Iliad Holdings LLC and JHW Iliad Holdings II LLC executed the reported Aveanna share sales. The Form 4 footnotes explain how J.H. Whitney-related entities and PSA-branded entities are structured and how they may share voting and dispositive power over these shares.

What Aveanna (AVAH) holdings remain after the reported insider sales?

After the June 3, 2026 sales, J.H. Whitney VII, L.P. held 13,450,547 Aveanna shares, JHW Iliad Holdings LLC held 2,412,602 and JHW Iliad Holdings II LLC held 252,899. Additional indirect holdings included 1,426,034 shares at PSA Iliad Holdings and 15,523,810 shares at PSA Healthcare Investment Holdings.

Does Paul R. Vigano directly own Aveanna (AVAH) shares after this Form 4?

The Form 4 reports zero Aveanna common shares held directly by Paul R. Vigano after the transactions. All reported positions are indirect, held through various investment entities, and the footnotes state he disclaims beneficial ownership except to the extent of his pecuniary interest.

Were there any Aveanna (AVAH) option exercises or derivatives in this Form 4?

No derivative securities or option exercises are reported in this Form 4. The derivative summary is empty, and all listed transactions involve non-derivative Aveanna common stock, primarily as open-market sales by indirect investment entities on June 3, 2026.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

VIGANO PAUL R

(Last) (First) (Middle)

C/O J.H. WHITNEY CAPITAL PARTNERS, LLC

212 ELM STREET

(Street)

NEW CANAAN CONNECTICUT 06840

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Aveanna Healthcare Holdings, Inc. [ AVAH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/03/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, $0.01 par value								0	D(4)
Common Stock, $0.01 par value	06/03/2026		S		5,842,240	D	$6.24	13,450,547	I	By J.H. Whitney VII, L.P.(1)
Common Stock, $0.01 par value								15,523,810	I	By PSA Healthcare Investment Holdings LLC(1)
Common Stock, $0.01 par value	06/03/2026		S		1,047,913	D	$6.24	2,412,602	I	By JHW Iliad Holdings LLC(2)
Common Stock, $0.01 par value								1,426,034	I	By PSA Iliad Holdings LLC(1)
Common Stock, $0.01 par value	06/03/2026		S		109,847	D	$6.24	252,899	I	By JHW Iliad Holdings II LLC(2)(3)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. J.H. Whitney Equity Partners VII, LLC ("Equity Partners VII") is the general partner of J.H. Whitney VII, L.P. ("JHW VII") and Whitney Strategic Partners VII, L.P. ("Strategic Partners VII"). Strategic Partners VII is the managing member of each of PSA Healthcare Investment Holdings LLC ("PSA Healthcare") and PSA Iliad Holdings LLC ("PSA Iliad Holdings"). As a result, Equity Partners VII may be deemed to share voting and dispositive power with respect to shares of common stock, $0.01 par value per share (the "Shares"), held by each of JHW VII, PSA Healthcare and PSA Iliad Holdings, and Strategic Partners VII may be deemed to share voting and dispositive power with respect to the Shares held by each of PSA Healthcare and PSA Iliad Holdings. Each of Equity Partners VII and Strategic Partners VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein.

2. Project Iliad Managing Member, LLC ("Project Iliad") is the managing member of JHW Iliad Holdings LLC ("JHW Iliad"). As a result, Project Iliad may be deemed to share voting and dispositive power with respect to the Shares held by JHW Iliad. Project Iliad disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein.

3. J.H. Whitney Capital Partners, LLC ("Capital Partners") is the sole member of J.H. Whitney VII Management Co., LLC ("Management Co. VII"), which is the managing member of JHW Iliad Holdings II LLC ("JHW Iliad II," and, collectively with PSA Healthcare, JHW Iliad, and PSA Iliad Holdings, the "Stockholder Entities"). As a result, each of Capital Partners and Management Co. VII may be deemed to share voting and dispositive power with respect to the Shares held by JHW Iliad II. Each of Capital Partners and Management Co. VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein.

4. Paul R. Vigano is a Managing Member of Equity Partners VII, a Member of Project Iliad and a Senior Managing Director of Capital Partners. As a result, the undersigned may be deemed to share voting and dispositive power with respect to the Shares held by the Stockholder Entities. The undersigned disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

	/s/ David Zatlukal, Attorney-in-Fact	06/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)